依托芬那酯结构式
|
常用名 | 依托芬那酯 | 英文名 | Etofenamate |
---|---|---|---|---|
CAS号 | 30544-47-9 | 分子量 | 369.335 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 451.1±45.0 °C at 760 mmHg | |
分子式 | C18H18F3NO4 | 熔点 | 25°C | |
MSDS | N/A | 闪点 | 226.6±28.7 °C |
依托芬那酯用途Etofenamate是非甾体抗炎化合物。 |
中文名 | 依托芬那酯 |
---|---|
英文名 | Etofenamate |
中文别名 | 2[[3-(三氟甲基)苯基]氨基]-2-(羟乙氧基)乙基苯甲酸酯 | 2-(2-羟基乙氧基)乙基 2-[3-(三氟甲基)苯胺基]苯甲酸酯 |
英文别名 | 更多 |
描述 | Etofenamate是非甾体抗炎化合物。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 451.1±45.0 °C at 760 mmHg |
熔点 | 25°C |
分子式 | C18H18F3NO4 |
分子量 | 369.335 |
闪点 | 226.6±28.7 °C |
精确质量 | 369.118805 |
PSA | 67.79000 |
LogP | 4.14 |
外观性状 | light yellow oil |
蒸汽压 | 0.0±1.2 mmHg at 25°C |
折射率 | 1.552 |
储存条件 | Refrigerator |
水溶解性 | Practically insoluble in water, miscible with ethanol (96 per cent) and with ethyl acetate. |
海关编码 | 2922509090 |
---|
~% 依托芬那酯 30544-47-9 |
文献:Arzneimittel-Forschung/Drug Research, , vol. 27, # 6 b p. 1300 - 1312 |
~% 依托芬那酯 30544-47-9 |
文献:Arzneimittel-Forschung/Drug Research, , vol. 27, # 6 b p. 1300 - 1312 |
海关编码 | 2922509090 |
---|---|
中文概述 | 2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:AB. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
监管条件 | A.入境货物通关单 B.出境货物通关单 |
检验检疫 | R.进口食品卫生监督检验 S.出口食品卫生监督检验 |
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Adverse reaction of topical etofenamate: petechial eruption.
West Indian Med. J. 61(7) , 767-9, (2012) Etofenamate is a non-steroidal anti-inflammatory drug (NSAID). Clinical findings caused by etofenamate are uncommon. Allergic contact dermatitis is the most common cutaneous reaction reported. But pet... |
|
Turpentine sensitization in a nonsteroidal anti-inflammatory solution user.
Dermatitis 23(4) , 182-3, (2012)
|
|
Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant.
Environ. Sci. Pollut. Res. Int. 19(5) , 1818-27, (2012) This study aimed to investigate the removal mechanisms of pharmaceutical active compounds (PhACs) and musks in a wastewater treatment plant (WWTP). Biological removal and adsorption in the activated s... |
Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-(2-hydroxyethoxy)ethyl ester |
2-(2-Hydroxyethoxy)ethyl fufenamate |
2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid 2-(2-Hydroxyethoxy)ethyl Ester |
Activon |
2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate |
Bayrogel |
N-(a,a,a-Trifluoro-m-tolyl)anthranilic Acid 2-(2-Hydroxyethoxy)ethyl Ester |
UNII-KZF0XM66JC |
2-(2-Hydroxyethoxy)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate |
Etofenamate |
Glasel |
Rheumon |
Rheumon gel |
Bayagel |